Bridging and downstaging with TACE in early and intermediate stage hepatocellular carcinoma: Predictors of receiving a liver transplant

• Published in: Annals of gastroenterological surgery Vol. 7; no. 2; pp. 295 - 305
• Main Authors: Yin, Chao, Armstrong, Samantha, Shin, Richard, Geng, Xue, Wang, Hongkun, Satoskar, Rohit S., Fishbein, Thomas, Smith, Coleman, Banovac, Filip, Kim, Alexander Y., He, Aiwu Ruth
• Format: Journal Article
• Language: English
• Published: Japan John Wiley & Sons, Inc 01.03.2023; John Wiley and Sons Inc; Wiley
• Subjects: Cancer therapies; Disease; downstage; Embolization; Hepatitis C; hepatocellular carcinoma; Liver cancer; liver transplant; Liver transplants; Medical prognosis; Milan Criteria; Original; Systematic review; transarterial chemoembolization; Tumors; transarterial chemoembolization; liver transplant; hepatocellular carcinoma; Milan Criteria; downstage

Background and Aims In patients with surgically unresectable early and intermediate stage hepatocellular carcinoma (HCC), only liver transplant (LT) offers a cure. Locoregional therapies, such as transarterial chemoembolization (TACE), are widely used to bridge patients waiting for an LT or downstag...